ECG
CVS icon

Edge Capital Group’s CVS Health CVS Stock Holding History

Edge Capital Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,887
Closed -$310K – 323
2024
Q1 		$310K Sell
3,887
-327
-8% -$25K 0.02% 258
2023
Q4 		$333K Buy
+4,214
New +$300K 0.02% 238
2023
Q3 		– Sell
-3,602
Closed -$249K – 296
2023
Q2 		$249K Buy
3,602
+2,290
+175% +$163K 0.01% 276
2023
Q1 		$97.5K Sell
1,312
-2,606
-67% -$219K 0.01% 339
2022
Q4 		$365K Sell
3,918
-1
-0% -$96 0.03% 226
2022
Q3 		$374K Sell
3,919
-68,201
-95% -$6.75M 0.03% 208
2022
Q2 		$6.18M Buy
72,120
+68,321
+1,798% +$6.67M 0.53% 45
2022
Q1 		$384K Sell
3,799
-120
-3% -$12.6K 0.03% 224
2021
Q4 		$404K Sell
3,919
-9
-0.2% -$832 0.03% 217
2021
Q3 		$333K Sell
3,928
-746
-16% -$62.5K 0.03% 219
2021
Q2 		$390K Sell
4,674
-310
-6% -$25.4K 0.03% 210
2021
Q1 		$375K Sell
4,984
-1,710
-26% -$125K 0.03% 207
2020
Q4 		$457K Buy
6,694
+1,767
+36% +$115K 0.04% 177
2020
Q3 		$288K Buy
+4,927
New +$307K 0.03% 198
2019
Q4 		– Sell
-7,534
Closed -$475K – 233
2019
Q3 		$475K Sell
7,534
-399
-5% -$23.6K 0.05% 166
2019
Q2 		$432K Buy
7,933
+393
+5% +$21.2K 0.04% 186
2019
Q1 		$407K Buy
7,540
+111
+1% +$6.85K 0.04% 188
2018
Q4 		$487K Buy
+7,429
New +$555K 0.05% 161

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Edge Capital Group's CVS Position: Q2 2024 in Review

Edge Capital Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,887 shares — an estimated $310K sold.

Edge Capital Group first reported a position in CVS in Q4 2018 and held it in 18 quarters. The position peaked at $6.18M in Q2 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Edge Capital Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Edge Capital Group sold 3,887 CVS Health shares in Q2 2024, an estimated $310K.
  • Edge Capital Group first reported a position in CVS Health in Q4 2018 and held it in 18 quarters.
  • Edge Capital Group's CVS Health position peaked at $6.18M in Q2 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Edge Capital Group's 13F filing for Q2 2024, filed 13 Aug 2024.